Help! Please Register

  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: The Fungi > Descriptions >


Candida famata var. famata
(Harrison) S.A. Meyer & Yarrow (Yarrow and Meyer 1978) (1985)

 
Teleomorph:

Debaryomyces hansenii (Zopf) Lodder & Kreger-van Rij var. hansenii (1985)

   
Candida famata var. flareri
(Ciferri & Redaelli) Nakase & Suzuki (1985b)

   
Teleomorph:

Debaryomyces hansenii var. fabryi (Ota) Nakase & M. Suzuki (1985b)
   


Macroscopic morphology

Colonies on Sabouraud dextrose agar at 25°C are grayish white to yellowish, dull to shiny, and smooth to wrinkled. The two varieties are distinguished by maximum growth temperature. Debaryomyces hansenii var. hansenii has a maximum growth temperature of 35°C while D. hansenii var. fabryi has a maximum growth temperature of 40°C and no growth on cycloheximide. This species is not distinguishable from several other species on Chromager Candida [1069].

Microscopic morphology

On cornmeal following 72 hours incubation at 25°C, usually no pseudohyphae are evident. Rare strains have rudimentary to well-developed pseudohyphae.

Special notes

Candida famata is an emerging pathogen that has been reported to have decreased susceptibility to amphotericin B [1775], [1776]. This species has been recovered from psoriasis, nails, and wounds [1270], the blood in a stem cell transplant patient [2347], and from the retina [382].

FTL* in vitro susceptibility data

AMB CAS 5FC FLU ITRA VORI
0.125 µg/ml=4 <0.03 µg/ml=5 <0.125 µg/ml=2 0.25 µg/ml=2 0.03 µg/ml=3 <0.015 µg/ml=3
0.25 µg/ml=3 0.25 µg/ml=2 2.0 µg/ml=1 0.5 µg/ml=4 0.06 µg/ml=2 0.03 µg/ml=3
  >16 µg/ml=1   1.0 µg/ml=4 0.25 µg/ml=2  
      2.0 µg/ml=2    
      4.0 µg/ml=3    


Drug/N AMB/7 CAS/8 5FC/3 FLU/15 ITRA/7 VORI/6
MIC Range 0.125-0.25 <0.03->16 <0.125-2.0 <0.125-4.0 0.03-0.25 <0.015-0.03
MIC50 * * * 1.0 * *
MIC90 * * * 4.0 * *
* Fungus Testing Laboratory unpublished data (NCCLS M27-A2)


Search

PubMed

Nucleotides

GenBank






References

382. Carrasco, L., M. Ramos, R. Galisteo, D. Pisa, M. Fresno, and M. E. Gonzalez. 2005. Isolation of Candida famata from a patient with acute zonal occult outer retinopathy. J Clin Microbiol. 43:635-40.

1069. Hospenthal, D. R., M. L. Beckius, K. L. Floyd, L. L. Horvath, and C. K. Murray. 2006. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob. 5:1.

1270. Kurtzman, C. P., and J. W. Fell (ed.). 2000. The Yeasts. A Taxonomic Study. Elsevier Scientific B.V., Amsterdam, The Netherlands.

1775. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, and R. N. Jones. 2003. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol. 41:78-83.

1776. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, and R. N. Jones. 2004. In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn Microbiol Infect Dis. 48:101-105.

2347. Wagner, D., A. Sander, H. Bertz, J. Finke, and W. V. Kern. 2005. Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. Infection. 33:397-400.



  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif